| Trial Identifier: | D8230C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03263637 |
| Start Date: | October 2017 |
| Primary Completion Date: | September 2021 |
| Study Completion Date: | September 2021 |
| Condition: | Leukemia; CLL (Chronic Lymphocytic Leukemia); Myeloma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Dutch Translation | |
| German Translation |
| Country | Location |
|---|---|
| Germany | Aachen, Germany, 52074 |
| Germany | Bonn, Germany, 53127 |
| Germany | Göttingen, Germany, 37075 |
| Germany | Heidelberg, Germany, 69120 |
| Germany | Ulm, Germany, 89081 |
| Netherlands | Amsterdam, Netherlands, 1105 AZ |
| Netherlands | Nieuwegein, Netherlands, 3435 CM |
| United Kingdom | Cardiff, United Kingdom, CF14 4XW |
| United Kingdom | Manchester, United Kingdom, M20 4BX |
| United Kingdom | PLYMOUTH, United Kingdom, PL6 8DH |
| United Kingdom | Southampton, United Kingdom, S016 6YD |
| United Kingdom | Sutton, United Kingdom, SM2 5PT |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company